High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$122K
$122,040
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Sell to Cover
2026-02-18
$3,862
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Sell to Cover
|
2026-02-18 | $3,862 | S | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-02-18 | $19,995 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Wilson Martin
• Officer • General Counsel
Sell to Cover
2026-02-18
$4,593
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • General Counsel
Sell to Cover
|
2026-02-18 | $4,593 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Sell to Cover
2026-02-13
$12,341
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Sell to Cover
|
2026-02-13 | $12,341 | S | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-02-13 | $40,668 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Wilson Martin
• Officer • General Counsel
Sell to Cover
2026-02-13
$40,582
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • General Counsel
Sell to Cover
|
2026-02-13 | $40,582 | S | Form 4 |